Interplay between oxidative stress and immunity in the progression of alcohol-mediated liver injury

Trends in Molecular Medicine

Volumn 14, Issue 2, 2008, Pages 63-71

  Vidali, Matteo ^a   Stewart, Stephen F ^b   Albano, Emanuele ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AUTOANTIBODY; CYTOCHROME P450 2E1; FREE RADICAL; IMMUNOGLOBULIN G ANTIBODY; LIVER PROTEIN; PHOSPHOLIPID; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL LIVER CIRRHOSIS; ALLOIMMUNITY; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMORAL IMMUNITY; INFLAMMATION; LIPID PEROXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN SYNTHESIS;

ALCOHOL DRINKING; ANIMALS; DISEASE PROGRESSION; FREE RADICALS; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; LIVER DISEASES, ALCOHOLIC; MODELS, BIOLOGICAL; OXIDATIVE STRESS; RATS;

RATTUS;

EID: 39149094259     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2007.12.005     Document Type: Article

References (82)

1. Maddrey W.C. Alcohol-induced liver disease. Clin. Liver Dis. 4 (2000) 115-131
2. Yip W.W., and Burt A.D. Alcoholic liver disease. Semin. Diagn. Pathol. 23 (2006) 149-160
3. Wilfred de Alwis N.M., and Day C.P. Genetics of alcoholic liver disease and non-alcoholic fatty liver disease. Semin. Liver Dis. 27 (2007) 44-54
4. Hines I.N., and Wheeler M.D. Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004) G310-G314
5. McClain C.J., et al. Recent advances in alcoholic liver disease IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004) G497-G502
6. Lalor P.F., et al. The role of cytokines and chemokines in the development of steatohepatitis. Semin. Liver Dis. 27 (2007) 173-193
7. Nelson S., and Kolls J.K. Alcohol, host defence and society. Nat. Rev. Immunol. 2 (2002) 205-209
8. Bautista A.P. Neutrophilic infiltration in alcoholic hepatitis. Alcohol 27 (2002) 17-21
9. Bataller R., and Brenner D.A. Liver fibrosis. J. Clin. Invest. 115 (2005) 209-218
10. Broad A., et al. Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy. Curr. Med. Chem. 13 (2006) 2487-2502
11. Ronis M.J., et al. Alcoholic liver disease in rats fed ethanol as part of oral or intragastric low-carbohydrate diets. Exp. Biol. Med. (Maywood) 229 (2004) 351-360
12. Albano E. Alcohol, oxidative stress and free radical damage. Proc. Nutr. Soc. 65 (2006) 278-290
13. Arteel G.E. Oxidant and antioxidant in alcohol-induced liver disease. Gastroenterology 124 (2003) 778-790
14. Nanji A.A. Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. Alcohol 34 (2004) 21-25
15. Seitz H.K., and Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat. Rev. Cancer 7 (2007) 599-612
16. Dey A., and Cederbaum A.I. Alcohol and oxidative liver injury. Hepatology 43 (2006) S63-S74
17. Gustot T., et al. Differential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 43 (2006) 989-1000
18. Nagy L.E. Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp. Biol. Med. (Maywood) 228 (2003) 882-890
19. Thakur V., et al. Chronic ethanol feeding increases activation of NADPH oxidase by liposaccharide in rat Kupffer cells: role of increased reactivite oxygen in LPS-stimulated ERK1/2 activation and TNF-α production. J. Leukoc. Biol. 79 (2006) 1348-1356
20. Haydon G., et al. Lymphocyte recruitment to the liver in alcoholic liver disease. Alcohol 27 (2002) 29-36
21. Colombat M., et al. Portal lymphocytic infiltrate in alcoholic liver disease. Hum. Pathol. 33 (2002) 1170-1174
22. Song K., et al. Chronic ethanol consumption by mice results in activated splenic T cells. J. Leukoc. Biol. 72 (2002) 1109-1116
23. Batey R.G., et al. Lymphocyte-mediated liver injury in alcohol-related hepatitis. Alcohol 27 (2002) 37-41
24. Minagawa M., et al. Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-α during alcohol consumption. Gastroenterology 126 (2004) 1387-1399
25. Godfrey D.I., and Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114 (2004) 1379-1388
26. Klassen L.W., et al. Immune mechanisms of alcohol-induced liver disease. Hepatology 22 (1995) 355-357
27. Albano E. Free radical mechanisms in immune reactions associated with alcoholic liver disease. Free Radic. Biol. Med. 32 (2002) 110-114
28. Mottaran E., et al. Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Radic. Biol. Med. 32 (2002) 38-48
29. Thiele G.M., et al. Immunological mechanisms of alcoholic liver disease. Semin. Liver Dis. 24 (2004) 273-287
30. Rolla R., et al. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease. Hepatology 31 (2000) 878-884
31. Stewart S.F., et al. Oxidative stress as a trigger for cellular immune response in patients with alcoholic liver disease. Hepatology 39 (2004) 197-203
32. Albano E., et al. Immune response toward lipid peroxidation products as a predictor of the progression of non-alcoholic fatty liver disease (NAFLD) to advanced fibrosis. Gut 54 (2005) 987-993
33. Rigamonti C., et al. Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C. Hepatology 38 (2003) 42-49
34. Choi J., and Ou J.H. Mechanisms of liver injury III. Oxidative stress in the pathogenesis of hepatitis C virus. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) G847-G851
35. Racanelli V., and Rehermann B. The liver as an immunological organ. Hepatology 43 (2006) S54-S62
36. Winau F., et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26 (2007) 117-129
37. Schneiderhan W., et al. Oxidized low-density lipoproteins bind to the scavenger receptor, CD36, of hepatic stellate cells and stimulate extracellular matrix synthesis. Hepatology 34 (2001) 729-737
38. Herkel J., et al. MCH class II-expressing hepatocytes function as antigen presenting cells and activate specific CD4 T lymphocytes. Hepatology 37 (2003) 1079-1085
39. Ma X., et al. A high fat diet and regulatory T cells influence the susceptibility to endotoxin-induced liver injury. Hepatology 46 (2007) 1519-1529
40. Li Z., et al. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 42 (2005) 880-885
41. Miyara M., and Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 13 (2007) 108-116
42. Laso J.F., et al. Cytokines and Alcohol Liver Disease. In: Sherman C.D.I.N., Preedy V.R., and Watson R.R. (Eds). Ethanol and the Liver (2002), Taylor and Francis 206-219
43. Ronis M.J.J., et al. Effects of N-acetyl cysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition. Free Radic. Biol. Med. 39 (2005) 619-630
44. Ronis, M.J.J. et al. (2008) Cytokine and chemokine expression associated with steatohepatitis and hepatocyte proliferation in rats fed ethanol via total enteral nutrition. Exp. Biol. Med. 233 (in press)
45. Tilg H., and Moschen A.R. Adipokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6 (2006) 772-783
46. Tilg H., and Hotamisligil G.S. Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 131 (2006) 934-945
47. Chen X., et al. Chronic ethanol feeding to rats decreases adiponectin secretion by subcutaneous adipocytes. Am. J. Physiol. Endocrinol Metab. 292 (2007) E621-E628
48. Naveau S., et al. Serum leptin in patients with alcoholic liver disease. Alcohol. Clin. Exp. Res. 30 (2006) 1422-1428
49. Ramaiah S.K., and Ritting S. Role of osteopontin in regulating hepatic inflammatory responses and toxic liver injury. Expert Opin. Drug Metab. Toxicol. 3 (2007) 519-526
50. Seth D., et al. Intrahepatic gene expression in human alcoholic hepatitis. J. Hepatol. 45 (2006) 306-320
51. Scatena M., et al. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 2302-2309
52. Chiocchetti A., et al. High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation. Blood 103 (2004) 1376-1382
53. McFarlane I.G. Autoantibodies in alcoholic liver disease. Addict. Biol. 5 (2000) 141-151
54. Vidali M., et al. Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease. Hepatology 37 (2003) 410-419
55. Neve E.P., and Ingelman-Sundberg M. Molecular basis for the transport of cytochrome P450 2E1 to the plasma membrane. J. Biol. Chem. 275 (2000) 17130-17135
56. Vidali M., et al. Use of molecular simulation for mapping conformational CYP2E1 epitopes. J. Biol. Chem. 279 (2004) 50949-50955
57. Longhi M.S., et al. Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Gastroenterology 46 (2007) 472-484
58. Stewart S.F., et al. Correlation between anti-CYP2E1 titres and lymphocyte infiltration in ALD an autoimmune disease in some patients. J. Hepatol. 40 Suppl. 1 (2004) 176
59. Palmer J.M., et al. Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse. Hepatology 39 (2004) 1583-1592
60. Gough S.C., et al. CTLA4 gene polymorphism and autoimmunity. Immunol. Rev. 204 (2005) 102-115
61. Bertolaccini M.L., et al. Revisiting antiphospholipid antibodies: from targeting phospholipid to phospholipid binding proteins. Clin. Lab. 50 (2004) 653-665
62. Levine J.S., et al. The antiphospholipid syndrome. N. Engl. J. Med. 346 (2002) 752-763
63. Rolla R., et al. Anti-phospholipid antibodies associated with alcoholic liver disease specifically recognize oxidized phospholipids. Gut 49 (2001) 852-859
64. Vay D., et al. Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranes. J. Hepatol. 44 (2006) 183-189
65. Savill J., et al. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2 (2002) 965-975
66. Kagan V.E., et al. Appetizing rancidity of apoptotic cells for macrophages: oxidation, externalization and recognition of phosphatidylserine. Am. J. Physiol. Lung Cell Mol. Physiol. 285 (2003) L1-L17
67. Natori S., et al. Hepatocyte apoptosis is a pathological feature of human alcoholic hepatitis. J. Hepatol. 34 (2001) 248-253
68. McVicker B.L., et al. The effect of ethanol on asialoglycoprotein receptor-mediated phagocytosis of apoptotic cells by rat hepatocytes. Hepatology 36 (2002) 1478-1487
69. Occhino G., et al. Immune responses induced by oxidative stress contribute to inflammation in alcoholic liver disease. Alcohol Alcohol. 42 Suppl. 1 (2007) 43
70. Krysko D.V., et al. Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis 11 (2006) 1709-1726
71. Munoz L.E., et al. The influence on the immunomodulatory effects of dying and death cells of annexin V. J. Leukoc. Biol. 81 (2007) 6-14
72. Canbay A., et al. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 38 (2003) 1188-1198
73. McVicker B.L., et al. Effect of chronic ethanol administration on the in vitro production of proinflammatory cytokines by rat Kupffer cells in the presence of apoptotic cells. Alcohol. Clin. Exp. Res. 31 (2007) 122-129
74. H2 paradigm. Nat. Rev. Immunol. 4 (2004) 583-594
75. Safadi R., et al. Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology 127 (2004) 870-882
76. Vidali M., et al. Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C. Am. J. Gastroenterol. 103 (2008) 147-153
77. Rao R.K., et al. Recent advances in alcoholic liver disease. I Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 286 (2004) G881-G884
78. Tilg H., and Day C.P. Management strategies in alcoholic liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 4 (2007) 24-34
79. Schwabe R.F., and Brenner D.A. Mechanisms of liver injury. I. TNF-α-induced liver injury: role of IKK, JNK and ROS pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) G583-G589
80. Fernandez-Checa J.C., and Kaplowitz N. Hepatic mitochondrial glutathione: transport and role in disease and toxicity. Toxicol. Appl. Pharmacol. 204 (2005) 263-273
81. Hoek J.B., and Pastorino J.G. Cellular signalling mechanisms in alcoholic liver damage. Semin. Liver Dis. 24 (2004) 257-272
82. Sampey B.P., et al. Ethanol-induced modulation of hepatocellular extracellular signal-regulated kinase 1/2 activity via 4-hydroxynonenal. J. Biol. Chem. 282 (2007) 1925-1937